Skip to main content
. 2015 Feb 20;8:63–79. doi: 10.2147/PGPM.S52845

Table 6.

Selected clinical trials targeting TP53

Drug Target(s) Tumor Phase Identifier*
rAd-p53 TP53 NSCLC II NCT01574729
Ad5CMV-p53 TP53 NSCLC I NCT00004225
Mutant p53 peptide vaccine mt-TP53 NSCLC II NCT00019929
AZD-1775 WEE1 Ovary II NCT01164995

Note:

*

Identifier from ClinicalTrials.gov.

Abbreviations: TP53, tumor protein p53; NSCLC, non-small cell lung cancer.